Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion.
Although platelet-activating factor (PAF) is implicated as an important mediator in the pathogenesis of hepatic ischemia-reperfusion (IR) injury, the precise mechanism of its action has not been studied. We examined the hypothesis that PAF may influence neutrophils by promoting the production of tumor necrosis factor alpha (TNF-alpha) and cytokine-induced neutrophil chemoattractant (CINC), a member of the interleukin-8 (IL-8) family, and may be associated with liver and lung injury during the early phase of reperfusion after total hepatic ischemia. Rats pretreated with a specific PAF receptor antagonist exhibited suppression of the increase in plasma TNF-alpha and CINC levels, as well as the priming of peripheral neutrophils for superoxide production after reperfusion when compared with animals pretreated with physiological saline. These effects resulted in a reduction of plasma liver enzymes and of hepatic and pulmonary neutrophil sequestration, as well as an increased survival rate. There was a strong correlation between the time course of CINC release and hepatic or pulmonary neutrophil sequestration. We concluded that PAF activates neutrophils, either directly or by promoting the production of TNF-alpha and CINC, and is involved in hepatic IR injury.
Serizawa
A
A
Second Department of Surgery, Hamamatsu University School of Medicine, Japan.
Nakamura
S
S
Suzuki
Baba
S
S
Nakano
M
M
D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D019743:Chemokines, CXC; D002630:Chemotactic Factors / Q000096:biosynthesis / Q000097:blood; D016207:Cytokines / Q000096:biosynthesis*; D006133:Growth Substances / Q000096:biosynthesis / Q000097:blood; D036341:Intercellular Signaling Peptides and Proteins; D008099:Liver / Q000293:injuries* / Q000473:pathology / Q000503:physiopathology*; D008168:Lung / Q000473:pathology; D008297:Male; D009504:Neutrophils / Q000473:pathology / Q000502:physiology*; D010972:Platelet Activating Factor / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D013481:Superoxides / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D019743:Chemokines, CXC; D002630:Chemotactic Factors; D016207:Cytokines; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D010972:Platelet Activating Factor; D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D001219:Aspartate Aminotransferases